Bixiye
QP64-25 Commercial Pharmacy Benefit Exclusion for Enflonsia™, Imuldosa™, Osenvelt®, Stoboclo®, Yeztugo® and Zusduri™
Taariikhda barnaamijka Dhaqangalayso Agosto 13, 2025
Natiijooyinka Raadinta
Soo bandhiga 2901 - 2910 ee natiijooyinka 4229
Bixiye
QP63-25 MHCP Pharmacy Benefit Exclusion for Enflonsia™, Lynozyfic™ and Zusduri™
Taariikhda barnaamijka Dhaqangalayso Agosto 13, 2025
Bixiye
QP61-25 Change in Replacement Claim Processing
Taariikhda barnaamijka Dhaqangalayso Agosto 13, 2025
Bixiye
QP45R1-25 Multiple Medicaid Coverages Listed on the Same Claim
Taariikhda barnaamijka Dhaqangalayso Agosto 13, 2025
Bixiye
QP68-25 MHCP Process for Behavioral Health Residential Prior Authorization (PA) Submission
Taariikhda barnaamijka Dhaqangalayso Agosto 13, 2025